Dementia with Lewy Bodies (DLB) Externally-Led Patient Focused Drug Development Meeting (EL-PFDD)
Автор: LBDAtv
Загружено: 2024-12-04
Просмотров: 2451
About the DLB EL-PFDD Meeting
The patient perspective is critical in helping the FDA understand the context in which regulatory decisions are made for new drugs. Patient-Focused Drug Development (PFDD) meetings give the FDA and other key stakeholders, including medical product developers, health care providers, federal agencies, an important opportunity to hear directly from patients, their families, care partners and patient advocates about the symptoms that matter most to them, the impact the disease has on their daily lives, and their experiences with currently available treatments.
Voice of the Patient Report
As an outcome of the EL-PFDD meeting, LBDA will publish the Voice of the Patient Report. This landmark report will include all the perspectives and shared experiences from the DLB community captured before, during and after the meeting, as well as a detailed summary and analysis of the data and insights. This report will be accessible via lbda.org and shared with the FDA, clinical researchers, drug developers and other key stakeholders as an important tool to guide and inform the development of better treatment options for those living with DLB.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![Почему взрываются батарейки и аккумуляторы? [Veritasium]](https://ricktube.ru/thumbnail/a3-3R9zwyGY/mqdefault.jpg)
